This article provides a comprehensive exploration of contemporary strategies for maximizing the sensitivity of liquid biopsy assays, a critical frontier in precision oncology.
Next-generation sequencing (NGS) has fundamentally transformed oncology, enabling comprehensive genomic profiling that guides precision therapy.
This article provides a comprehensive overview of the current landscape of microsatellite instability (MSI) testing, a critical biomarker for Lynch syndrome screening, prognosis, and predicting response to immunotherapy.
This article provides a comprehensive analysis of current and emerging molecular techniques for Minimal Residual Disease (MRD) monitoring, a critical tool in precision oncology.
Digital PCR (dPCR) represents a third-generation PCR technology that enables absolute, calibration-free quantification of nucleic acids, revolutionizing molecular analysis in oncology.
This article provides a comprehensive overview of Sanger sequencing's pivotal role in single-gene cancer testing for researchers and drug development professionals.
This article provides a comprehensive overview of liquid biopsy and circulating tumor DNA (ctDNA) analysis, tailored for researchers, scientists, and drug development professionals.
This comprehensive review explores the pivotal roles of oncogenes and tumor suppressor genes in cancer pathogenesis, tracing their discovery from foundational theories like Knudson's two-hit hypothesis to contemporary multi-omics approaches.
This article provides a comprehensive guide to next-generation sequencing (NGS) protocols for tumor profiling, tailored for researchers, scientists, and drug development professionals.
This article synthesizes current evidence and strategies for identifying candidates for hereditary cancer genetic testing, a critical step in precision oncology that remains significantly underutilized.